Urethral strictures refer to the narrowing of the urethra, which is the tube that carries urine out of the body. This condition is typically caused by scarring, which can block or narrow the urethra, ...

Guidelines for male urethral stricture The guidelines provide a clinical framework for the diagnosis and treatment of male urethral stricture. A clinical framework to guide providers in the diagnosis ...

TOKYO--(BUSINESS WIRE)--Treating male urethral stricture with the patient’s own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan. A longer ...

The Optilume device includes a balloon coated with paclitaxel. The Food and Drug Administration (FDA) has approved the Optilume ® Urethral Drug Coated Balloon (DCB) to treat patients with obstructive ...

TOKYO--(BUSINESS WIRE)--A novel and relatively pain-less treatment method for male urethral stricture using patients own buccal mucosal cells has been reported as successful in four out of six ...

Synchronous metastatic disease is characterized by the presence of metastatic lesions, in addition to the primary tumor, at diagnosis. Investigators in South Korea demonstrated the benefit in a ...

A team of surgeons in the University College Hospital (UCH), Ibadan, led by Prof. Olayinka Shittu, has successfully performed an intricate procedure to reconstruct a urethral stricture in a ...

Optilume is a urethral balloon coated with paclitaxel (3.5 microgram/mm 2). It is indicated for managing urethral stricture disease in 'adult males'. It is designed to be used as a drug-coated ...

Treating male urethral stricture with the patient’s own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan. A longer duration of relief to patients ...

NICE commissioned an external assessment centre (EAC) to review the evidence submitted by the company. This section summarises that review. Full details of all the evidence are in the project ...